Welcome to our dedicated page for Honeywell Intl SEC filings (Ticker: HON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Honeywell International Inc. (NASDAQ: HON), including current reports on Form 8-K and other key documents. These filings offer detailed information on Honeywell’s segment structure, portfolio actions, financing arrangements, governance changes and material events.
Honeywell’s recent 8-K filings describe several significant corporate developments. The company has reported on the completed spin-off of its Advanced Materials business into Solstice Advanced Materials Inc., which now trades separately on Nasdaq under the ticker SOLS, and on the planned separation of its global Aerospace Technologies business into an independent, publicly traded company. Other filings outline the realignment of Honeywell’s reportable segments into Aerospace Technologies, Building Automation, Process Automation and Technology, and Industrial Automation, with additional operations in Corporate and All Other.
Filings also detail capital markets activity and liability management. Honeywell lists multiple series of senior notes on Nasdaq, and its 8-Ks identify these securities and their terms. The company has disclosed the permanent divestiture of certain legacy asbestos liabilities through the sale of a subsidiary holding those liabilities and related insurance assets, and has described an agreement with Resideo Intermediate Holding Inc. to terminate an indemnification and reimbursement arrangement via a one-time cash payment, subject to closing conditions.
Through Stock Titan, users can monitor new Honeywell filings as they are posted to EDGAR and use AI-powered summaries to interpret complex documents such as Form 8-Ks, 10-K annual reports, 10-Q quarterly reports and proxy materials. The filings page is a central resource for understanding Honeywell’s regulatory disclosures, including segment realignments, spin-offs, leadership changes and significant agreements affecting HON shareholders and bondholders.
Honeywell International Inc. director Duncan Angove exercised restricted stock units into common shares. On April 15, 2026, 625 restricted stock units converted into 625 shares of common stock on a one-for-one basis, reflecting vested awards under the 2016 Stock Plan for Non-Employee Directors.
The restricted stock units, including 13 additional units from reinvested dividend equivalents, vested on April 15, 2026. Following the conversion, Angove directly holds 3,608 shares of Honeywell common stock, and no remaining restricted stock units are shown in this filing.
Honeywell International Inc. director D. Scott Davis reported an exercise of equity awards into common stock. On April 15, 2026, he converted 625 Restricted Stock Units into 625 shares of Honeywell common stock at a price of $230.93 per share and held 31,721 shares afterward.
The Restricted Stock Units were granted under Honeywell’s 2016 Stock Plan for Non-Employee Directors and vested on April 15, 2026. The grant also included the reinvestment of dividend equivalents into 13 additional restricted stock units, and the instrument converts to common stock on a one-for-one basis.
Honeywell International director Grace Lieblein exercised 625 Restricted Stock Units into the same number of shares of common stock on April 15, 2026. The common stock entry shows a transaction price of $230.93 per share, reflecting the market value at conversion.
The RSUs were granted under Honeywell’s 2016 Stock Plan for Non-Employee Directors and vested on April 15, 2026, and the award included the reinvestment of dividend equivalents into 13 additional RSUs. Following this transaction, Lieblein directly holds 16,564 shares of Honeywell common stock, with no sales or dispositions reported in this filing.
Honeywell International director Robin Watson exercised equity awards and settled related taxes in shares. On April 15, 2026, 625 Restricted Stock Units, including 13 units from dividend equivalent reinvestment, converted into 625 shares of Honeywell common stock on a one-for-one basis. Of these, 188 shares were withheld to cover tax obligations at a reference price of $230.93 per share, leaving Watson with 1,493 common shares held directly. The Restricted Stock Units were granted under Honeywell’s 2016 Stock Plan for Non-Employee Directors and vested on April 15, 2026, making this a routine, compensation-related exercise-and-tax-withholding event rather than an open-market trade.
Honeywell International Inc. director Kevin Burke exercised restricted stock units into common shares. On April 15, 2026, 625 restricted stock units, including 13 from dividend-equivalent reinvestment, converted one-for-one into 625 shares of common stock at $230.93 per share. After the transaction, Burke directly holds 29,532 Honeywell shares, and no shares were sold, reflecting routine vesting under the 2016 Stock Plan for Non-Employee Directors.
Honeywell International Inc. director Michael W. Lamach exercised restricted stock units into common stock. On April 15, 2026, 625 restricted stock units converted into 625 shares of Honeywell common stock on a one-for-one basis, with the common stock transaction reported at $230.93 per share.
The units were granted under Honeywell’s 2016 Stock Plan for Non-Employee Directors and vested on April 15, 2026, including 13 additional units from reinvested dividend equivalents. Following the transaction, Lamach directly held 2,278 shares of Honeywell common stock.
Honeywell International director William S. Ayer exercised restricted stock units into common shares, increasing his direct equity stake. On April 15, 2026, 625 Restricted Stock Units converted into 625 shares of Honeywell common stock on a one-for-one basis at a stated transaction price of $230.93 per share.
The Restricted Stock Units were granted under Honeywell’s 2016 Stock Plan for Non-Employee Directors and vested on April 15, 2026, including 13 units from reinvested dividend equivalents. Following the transaction, Ayer directly holds 11,968 shares of Honeywell common stock, with no remaining units from this award.
Honeywell International director Craig Arnold exercised restricted stock units and received common shares as compensation. On April 15, 2026, he converted 359 restricted stock units into 359 shares of Honeywell common stock at an indicated value of $230.93 per share. The units, including 4 from dividend equivalent reinvestments, were granted under the 2016 Stock Plan for Non-Employee Directors and fully vested on that date. After the transaction, Arnold directly holds 359 common shares from this award and no remaining restricted stock units from this grant.
Honeywell International Inc. director Stephen Williamson exercised restricted stock units into common shares. On April 15, 2026, 625 restricted stock units converted into 625 shares of common stock on a one-for-one basis, at a reported transaction price of $230.93 per share.
The restricted stock units were granted under Honeywell’s 2016 Stock Plan for Non-Employee Directors and vested on April 15, 2026, including 13 additional units from reinvested dividend equivalents. Following the transaction, Williamson holds 789 shares of common stock directly and no units from this grant remain outstanding.
Honeywell International director Indra K. Nooyi exercised restricted stock units into common shares as part of her board compensation. On April 15, 2026, 256 restricted stock units, including 1 unit from dividend equivalent reinvestment, converted into 256 common shares on a one-for-one basis at a stated price of $230.93 per share. These units were granted under Honeywell’s 2016 Stock Plan for Non-Employee Directors and vested on April 15, 2026, resulting in direct ownership of 256 common shares reported in this filing.